Jesus Duque–Afonso, C. L. (2018). CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationJesus Duque–Afonso, Chiou–Hong Lin. CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationJesus Duque–Afonso, Chiou–Hong Lin. CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.